Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-05-04
1992-05-26
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
051168456
ABSTRACT:
The novel antitumor antibiotic designated herein as BU-3420T is produced by fermentation of Micromonospora chersina strain M956-1 (ATCC 53710). BU-3420T and its triacetate derivative possess antibacterial and antifungal activity and also inhibit the growth of mammalian tumors such as P388 leukemia in mice.
REFERENCES:
patent: 4530835 (1985-07-01), Bunge et al.
patent: 4578271 (1986-03-01), Kiyoto et al.
patent: 4661353 (1987-04-01), Wilton et al.
patent: 4675187 (1987-06-01), Konishi et al.
patent: 4916065 (1990-04-01), Ohkuma et al.
Hoshino Yutaka
Konishi Masataka
Matsumoto Kiyoshi
Ohkuma Hiroaki
Oki Toshikazu
Bristol-Myers Company
Friedman Stanley J.
Han William T.
Morse David M.
Weddington Kevin E.
LandOfFree
BU-3420T antitumor antibiotic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with BU-3420T antitumor antibiotic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and BU-3420T antitumor antibiotic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-419967